Teague C, Markovic T, Zhou X, Martinez-Rivera F, Minier-Toribio A, Zinsmaier A
J Neurosci. 2024; 44(23).
PMID: 38637154
PMC: 11154853.
DOI: 10.1523/JNEUROSCI.1327-23.2024.
Kochoian B, Bure C, Papa S
Cells. 2023; 12(23).
PMID: 38067182
PMC: 10706484.
DOI: 10.3390/cells12232754.
Kolb M, Crestani B, Maher T
Eur Respir Rev. 2023; 32(167).
PMID: 36813290
PMC: 9949383.
DOI: 10.1183/16000617.0206-2022.
Masilamoni G, Sinon C, Kochoian B, Singh A, McRiner A, Leventhal L
Neuropharmacology. 2022; 212:109060.
PMID: 35461880
PMC: 11698471.
DOI: 10.1016/j.neuropharm.2022.109060.
Schroder S, Scheunemann M, Wenzel B, Brust P
Int J Mol Sci. 2021; 22(8).
PMID: 33917199
PMC: 8068090.
DOI: 10.3390/ijms22083832.
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders.
Delhaye S, Bardoni B
Mol Psychiatry. 2021; 26(9):4570-4582.
PMID: 33414502
PMC: 8589663.
DOI: 10.1038/s41380-020-00997-9.
Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease.
Chakroborty S, Manfredsson F, Dec A, Campbell P, Stutzmann G, Beaumont V
Front Neurosci. 2020; 14:466.
PMID: 32581668
PMC: 7283904.
DOI: 10.3389/fnins.2020.00466.
Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance.
John J, Bhattacharyya U, Yadav N, Kukshal P, Bhatia T, Nimgaonkar V
Schizophr Res. 2019; 216:288-294.
PMID: 31813803
PMC: 8958857.
DOI: 10.1016/j.schres.2019.11.041.
Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide.
Harms J, Menniti F, Schmidt C
Front Neurosci. 2019; 13:837.
PMID: 31507355
PMC: 6716477.
DOI: 10.3389/fnins.2019.00837.
Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus.
McQuown S, Xia S, Baumgartel K, Barido R, Anderson G, Dyck B
Front Mol Neurosci. 2019; 12:21.
PMID: 30792627
PMC: 6374598.
DOI: 10.3389/fnmol.2019.00021.
Targeting the dopamine D receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.
Pekcec A, Schulert N, Stierstorfer B, Deiana S, Dorner-Ciossek C, Rosenbrock H
Br J Pharmacol. 2018; 175(14):3021-3033.
PMID: 29726015
PMC: 6016630.
DOI: 10.1111/bph.14350.
Phosphodiesterase-1b deletion confers depression-like behavioral resistance separate from stress-related effects in mice.
Hufgard J, Williams M, Vorhees C
Genes Brain Behav. 2017; 16(8):756-767.
PMID: 28488329
PMC: 5677534.
DOI: 10.1111/gbb.12391.
Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a.
Hufgard J, Williams M, Skelton M, Grubisha O, Ferreira F, Sanger H
Psychopharmacology (Berl). 2017; 234(12):1803-1813.
PMID: 28337525
DOI: 10.1007/s00213-017-4587-8.
Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?.
Nthenge-Ngumbau D, Mohanakumar K
Mol Neurobiol. 2017; 55(1):822-834.
PMID: 28062949
DOI: 10.1007/s12035-016-0355-8.
Alterations of Phosphodiesterases in Adrenocortical Tumors.
Hannah-Shmouni F, Faucz F, Stratakis C
Front Endocrinol (Lausanne). 2016; 7:111.
PMID: 27625633
PMC: 5003917.
DOI: 10.3389/fendo.2016.00111.
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.
Heckman P, Van Duinen M, Bollen E, Nishi A, Wennogle L, Blokland A
Int J Neuropsychopharmacol. 2016; 19(10).
PMID: 27037577
PMC: 5091819.
DOI: 10.1093/ijnp/pyw030.
Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies.
Ye H, Wang X, Sussman C, Hopp K, Irazabal M, Bakeberg J
J Am Soc Nephrol. 2015; 27(5):1312-20.
PMID: 26374610
PMC: 4849815.
DOI: 10.1681/ASN.2015010057.
Phosphodiesterases and adrenal Cushing in mice and humans.
Szarek E, Stratakis C
Horm Metab Res. 2014; 46(12):863-8.
PMID: 25232906
PMC: 4730987.
DOI: 10.1055/s-0034-1389916.
Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
Ahmad F, Murata T, Shimizu K, Degerman E, Maurice D, Manganiello V
Oral Dis. 2014; 21(1):e25-50.
PMID: 25056711
PMC: 4275405.
DOI: 10.1111/odi.12275.
Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition.
Threlfell S, West A
Basal Ganglia. 2014; 3(3):137-146.
PMID: 24490129
PMC: 3904398.
DOI: 10.1016/j.baga.2013.08.001.